Global Chlamydia Diagnosis and Treatment Market Research and Forecast 2018-2023

  • ID: 4602798
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4


  • Abbott Laboratories
  • Akers Biosciences, Inc.
  • Clinical Lab Product
  • Hologic Inc
  • Quidel Corporation
  • Sysmex Corporation
  • MORE
Chlamydia trachomatis is a type of sexually transmitted disease that is prevalent in population of all age group, but women are much more vulnerable to it. The Chlamydia diagnosis involves a series of test such as urine culture, Nucleic acid amplification tests, Enzyme immunoassays and so on. The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in use of rapid point of care diagnosis kits also propel the market. The treatment of this disease is prolonged and usually achieved by administration of oral antibiotics to the patients. The lack of skilled practitioners for performing diagnostic test and the high cost of the tests such as Nucleic acid amplification test is the major factor for growth hindrance of market. The awareness, supportive government regulations and increased funding on development of novel diagnostic method will drive the growth of market in the forecasted period.

The market is divided into North America, Europe, Asia Pacific and Rest of the World geographically. North America region captures the major market share of Chlamydia diagnosis and treatment market due to high prevalence of disease in the region. The region also has leading diagnostic companies making it the most revenue generating region. The APAC region will grow significantly in the projected period due to rapid development in the economies and large investment in healthcare sector. The European region also holds the substantial share of the Chlamydia Diagnosis market.

The competition in Chlamydia Diagnosis market is moderate as relatively low number of companies are present in the segment, the market players are engaged in providing diagnostic tests such as Nucleic acid amplification test, Enzyme immunoassays test and rapid diagnostic test kits. The Key Players in the Chlamydia Diagnosis market are Abbott Laboratories, Hologic Inc, Laboratory Corporation of America, Novartis Diagnostics, Qiagen, Quidel Corporation, Roche Molecular Systems Inc., Siemens AG, Synapse Diagnostics, Sysmex corporation, Thermo Fisher Scientific, Tosoh Corporation and so on. The companies are also engaged in rapid research and development for the development of rapid diagnostic test kits for effective diagnosis of the disease.

Research Methodology

The market study of Global Chlamydia Diagnosis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the market
Authentic Public Databases (org, gov and other such websites)
Whitepapers such, research-papers and news blogs
Company websites and their product catalogue.

The Report is intended for Emerging companies and researchers in the market, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in market, product types. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

Market Segmentation:

Global Chlamydia Disease Market is segmented on the basis of various regions and below mentioned segments:
Global Chlamydia Diagnosis Market Research and Analysis, By Diagnosis method
Global Chlamydia Diagnosis Market Research and Analysis, By Treatment approach
Global Chlamydia Diagnosis Market Research and Analysis, By End user

The Report covers:

Comprehensive research methodology of Global Chlamydia Diagnosis market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Chlamydia Diagnosis
Insights about market determinants which are stimulating the Global Chlamydia Diagnosis
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 4


  • Abbott Laboratories
  • Akers Biosciences, Inc.
  • Clinical Lab Product
  • Hologic Inc
  • Quidel Corporation
  • Sysmex Corporation
  • MORE
1. Report Summary
1.1. Research Methods And Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview And Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation United States European Union China India

3. Market Determinant
3.1. Motivators
3.1.1. Increasing Prevalence Of The Chlamydia Trachomatis Disease
3.1.2. Change In Life Style
3.1.3. Increased Adoption Of Point Of Care Diagnostic Tests
3.1.4. Increased Government Funding And Awareness Regarding Diagnosis And Treatment
3.2. Restraint
3.2.1. Low Awareness In Developing Countries
3.2.2. Preventive Measures For Stds
3.3. Opportunity
3.3.1. Rapid Development And Adoption Of Non-Invasive, Cheap And Reliable Diagnosis Technologies.
3.3.2. Microfluid Diagnostic Technologies Are Entering The Market

4. Market Segmentation
4.1. Global Chlamydia Market, By Diagnosis Methods
4.1.1. Chlamydia Culture
4.1.2. Urine Culture
4.1.3. Enzyme Immunoassays
4.1.4. Nucleic Acid Amplification Test
4.2. Global Chlamydia Market, By Treatment Approach
4.2.1. Oral Antibiotics Azithromycin Doxycycline Other
4.3. Global Chlamydia Diagnosis And Treatment Market, By End-User
4.3.1. Hospitals
4.3.2. Diagnostic Centres
4.3.3. Research Institutions

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada

6.2. Europe
6.2.1. Uk
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest Of Europe
6.3. Apac
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest Of Apac
6.4. Rest Of The World

7. Company Profiles
7.1. Abbott Laboratories
7.2. Aetna Inc
7.3. Agilent Technologies
7.4. Akers Biosciences, Inc.
7.5. Bio-Rad Laboratories, Inc
7.6. Cigna
7.7. Clinical Lab Product
7.8. Diadexus
7.9. Erba Diagnostics
7.10. Hologic Inc
7.11. Laboratory Corporation Of America
7.12. Novartis Diagnostics
7.13. Qiagen
7.14. Quidel Corporation
7.15. Roche Molecular Systems Inc.
7.16. Siemens Ag,
7.17. Synapse Diagnostics
7.18. Sysmex Corporation
7.19. Thermo Fisher Scientific
7.20. Tosoh Corporation
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Abbott Laboratories
  • Aetna Inc
  • Agilent Technologies
  • Akers Biosciences, Inc.
  • Bio-Rad Laboratories, Inc
  • Cigna
  • Clinical Lab Product
  • Diadexus
  • Erba Diagnostics
  • Hologic Inc
  • Laboratory Corporation Of America
  • Novartis Diagnostics
  • Qiagen
  • Quidel Corporation
  • Roche Molecular Systems Inc.
  • Siemens Ag,
  • Synapse Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown